Table 3.
Serotype | N | MDR only* (N = 20), N (%) | DCS only† (N = 4), N (%) | Both MDR and DCS (N = 10), N (%) | No resistance (N = 15), N (%) |
---|---|---|---|---|---|
Non-typhoidal | 35 | 19 (54) | 0 (0) | 1 (3) | 15 (43) |
Enteritidis | 21 | 17 (81) | 0 (0) | 0 (0) | 4 (19) |
Typhimurium | 13 | 1 (8) | 0 (0) | 1 (8) | 11 (84) |
I 4,[5],12:i:- | 1 | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
Typhi | 14 | 1 (7) | 4 (29) | 9 (64) | 0 (0) |
DCS = decreased ciprofloxacin susceptibility; MDR = multi-drug resistant.
MDR isolates exhibited resistance to at least one antibiotic in three or more drug classes. Nineteen non-typhoidal isolates were resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole. One Salmonella enteritidis isolate was resistant to ampicillin, streptomycin, sulfisoxazole, and tetracycline, but susceptible to chloramphenicol and trimethoprim-sulfamethoxazole.
Isolates with DCS exhibited resistance to nalidixic acid and were intermediate to ciprofloxacin.